Brief: Extrawell Pharmaceutical Expects FY Loss Of At Least HK$950 Million
23/06/2026 16:16
BRIEF-Extrawell Pharmaceutical Expects FY Loss Of At Least HK$950 Million June 23 (Reuters) - Extrawell Pharmaceutical Holdings Ltd 0858.HK:
EXPECTS LOSS OF AT LEAST HK$950 MILLION FOR YEAR ENDED 31 MARCH 2026
EXPECTED RESULT DUE TO UNREALISED LOSS HK$800 MILLION-HK$850 MILLION ON STARCOIN GROUP CONVERTIBLE BONDS, OTHERS IN FY
Further company coverage: 0858.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Extrawell Pharmaceutical Holdings
See all newsBrief: Extrawell Pharmaceutical Abandons Negotiations For Possible Sale Of Convertible Bonds
Brief: Extrawell Pharmaceutical Proposes Share Consolidation Of 20 Shares Into 1 Share Of HK$0.20 Par Value
Brief: Extrawell Pharmaceutical Says Mr. Wu Xiangyun Appointed As Executive Director
Brief: Extrawell Pharmaceutical Expects FY Loss Of At Least HK$950 Million
Brief: Extrawell Pharmaceutical's Unit To Buy Back 10.06% Of Its Stake For RMB4.4 Million